Überwachung von COVID-19 durch Erweiterung der etablierten Surveillance für Atemwegsinfektionen
Luise Goerlitz(Robert Koch Institute), Silke Buda(Robert Koch Institute), Kristin Tolksdorf(Robert Koch Institute), Kerstin Prahm(Robert Koch Institute), Walter Haas(Robert Koch Institute), Ralf Dürrwald(IDT Biologika (Germany)), Udo Buchholz(Robert Koch Institute), Janine Michel(Robert Koch Institute), Thorsten Wolff(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Ute Preuß(Robert Koch Institute), Andreas Nitsche(Altera (United States))
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
March 24, 2021
Cited by 13
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage
|Nature Communications|2019|1.2k
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718